In Harry Potter, Mad-Eye Moody died as he lived, a fighter. But not showing his death hindered his legacy and was a ...

By Tony Maglio We don’t have to say au revoir to Lupin, merci. Part four of the hit series is already in production in Paris, Netflix said on Monday; it will consist of eight 45-minute episodes.

Lupin has launched eslicarbazepine acetate tablets, 200 mg, 400 mg, 600 mg and 800 mg. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity ...

Netflix has confirmed the fourth season of hit French series Lupin with Omar Sy in the lead role as production begin in Paris. Sy will reprises his iconic role as Assane Diop, the gentleman thief ...

Signature Entertainment has announced it has acquired the U.K., Irish and Latin American rights to horror “The Beldham” from the Coven. The feature is produced by Talia Bella (“Cottonmouth ...

Mumbai: Indian generics drug maker, Lupin wholly owned diagnostic arm Lupin Diagnostics Limited (LDL) has obtained NABL (National Accreditation Board for Testing and Calibration Laboratories ...

Lupin is no stranger to recalls, and has at times even had to suspend production of U.S.-bound drugs at its plants. In late November, Lupin recalled more than 600,000 bottles of the high blood ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood ...

Shares of Lupin Ltd. edged 2.5 percent higher on Wednesday after the company announced the launch of Tolvaptan tablets in the US market, marking a key milestone in its US generics portfolio.

Lupin has received the Food and Drug Administration’s permission for tolvaptan tablets, 15 mg, 30 mg, 45 mg, 60 mg and 90 mg. Tolvaptan tablets are the generic of Otsuka’s Jynarque. Lupin is ...

“I often say that Lupin is an extraordinary plaything. I find great joy in it every time,” Sy said in a statement Monday. “Together with Netflix, Carrousel and Gaumont, we’ve invested the time needed ...